News
The latest news, stories, and updates from the Children's Tumor Foundation.
Filter
AllAdvocacyAwards & GrantsAwarenessCollaborations & PartnershipsCovid-19CTF in the NewsCupid's Undie Run (CUR)FeaturedFeatured EUFundraiserGlobalNewsletterNF Clinic Network (NFCN)NF ConferenceNF EnduranceNF RegistryNF SummitNF1NF2-SWNOutside OpportunitiesPatient EngagementPharmaPress ReleasePublicationsScience & ResearchShine A Light Walk (SALW)Special EventsStory of NFSWNThis Is NFTools for KidsTop StoryTop Story EUUncategorizedVideoWays to Give
Collaborations & PartnershipsGlobalPress Release
Children’s Tumor Foundation’s Montse Montaner Joins CureAge Therapeutics
Seasoned international advisor will serve on the board of CureAge Therapeutics The Children's Tumor Foundation…
CTF in the NewsPharma
Children’s Tumor Foundation Featured in Two-Part Series in BioSpace on Reviving Abandoned Drugs for Rare Disease Treatments
The Children's Tumor Foundation (CTF) is spotlighted in two parts in the life science publication…
AdvocacyAwarenessFeaturedFeatured EUPharma
From NF to the World: Rare Disease Day and the Race for Faster Treatments
This has been a February to remember! In just a few weeks, a new drug…
NF1Story of NF
Story of NF: Jonah S.
I was diagnosed at birth. Unidentified Bright Spots were found during an MRI when I…
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaPress ReleaseScience & Research
Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of NF1
Healx has dosed the first patient in its Phase 2 trial for HLX-1502 - the…
Featured EU
CTF Europe Brochure in Multiple Languages
We are pleased to share our new trifold brochure about CTF Europe, now available in…
FeaturedNF Clinic Network (NFCN)NF1NF2-SWNPress ReleaseSWN
UF Health Jacksonville joins the NF Clinic Network
Enhancing Clinical Care for Neurofibromatosis and Schwannomatosis Patients UF Health Jacksonville joins the NF…
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaPress ReleaseScience & Research
CureAge Therapeutics Launches to Advance Genetic Therapies for Neurofibromatosis
Children’s Tumor Foundation and Deep Science Ventures Spearhead New Biotech to Develop Curative Treatments for…
Science & Research
NF Science Explained: Research Links Immune Cells to Tumor Growth in Vestibular Schwannomas
In this article, the Children’s Tumor Foundation offers a patient-friendly summary of a scientific publication…
NF1PharmaScience & ResearchTop StoryTop Story EU
IT’S A GO! NF’s NEXT BIG WIN!
Today, we make history... again! The FDA has officially approved Gomekli (mirdametinib) - the second-ever…
NF Clinic Network (NFCN)
NF Clinic Network Expansion: Recently Joined NF Clinics
The Children's Tumor Foundation (CTF) is thrilled to recognize the new clinics that joined the…